Loading, Please Wait...
WELLESLEY, MA --(Marketwired - February 04, 2016) - World Cancer Day forges a global initiative on Feb. 4 under which the world can unite together in the fight against the global cancer epidemic.
An initiative of the Union for International Cancer Control (UICC), World Cancer Day aims to save millions of preventable deaths each year by raising awareness and education about cancer while enjoining governments and individuals world to take action against the disease.
WORLD CANCER DECLARATION
This year alone, almost eight million people will die of cancer, and left unchecked, the number of deaths will rise to 13.2 million per year by 2030, according to UICC.
The World Cancer Declaration calls upon government leaders and health policy-makers to significantly reduce the global cancer burden, promote greater equity, and integrate cancer control into the world health and development agenda.
UICC developed the World Cancer Declaration to help bring the growing cancer crisis to the attention of government leaders and health policymakers. The nine declaration targets, designed to significantly reduce the global cancer burden by 2020, have served as the basis for UICC recommendations to the World Health Organization (WHO).
Among the nine declaration targets:
Universal vaccination programs for hepatitis B (HBV) and human papillomavirus (HPV) to prevent liver and cervical cancer. Vaccines are biological preparations that boost the immune system's natural ability to protect the body against infectious agents that may cause disease, explains analyst Shalini S. Dewan. "Some vaccines may help prevent certain cancers, as some cancers are caused by viruses."
She says that vaccines that help protect against infection with these viruses might also help prevent some of these cancers. "Some strains of the human papillomavirus have been associated with cervical, anal, throat and some other cancers. Vaccines against HPV may help protect against some of these cancers. People with chronic infections of hepatitis B virus are at higher risk for liver cancer. Getting the vaccine to help prevent HBV infection may therefore lower the risk of developing liver cancer."
Universal access to screening and early detection of cancer. The World Health Organization (WHO) predicts that global cancer incidence will rise to 17 million new cases by 2020, an increase of 50% over the 2005 rate. Newer biotherapeutics have emerged in the past few years that have had significant impacts on cancer treatment and healthcare, according to BCC Research analyst Usha Nagavarapu. Achievements in the field of genomics, proteomics and biomarker research are paving the path for new biologic therapies, promising to be significantly more effective compared to current treatment choices.
Strengthen healthy systems for effective cancer control. "Radiation therapy is the most common treatment to kill cancer cells in an attempt to cure or control the cancer," says Neha Maliwal, BCC Research analyst. "Success and control rates have improved as better planning has been achieved by new equipment, new computer programs, more precise dosages and better quality control."
About BCC Research
BCC Research publishes market research reports that make organizations worldwide more profitable with intelligence that drives smart business decisions. These reports cover today's major industrial and technology sectors, including emerging markets. For more than 40 years we've helped customers identify new market opportunities with accurate and reliable data and insight, including market sizing, forecasting, industry overviews, and identification of significant trends and key market participants. We partner with analysts who are experts in specific areas of industry and technology, providing unbiased measurements and assessments of global markets. Recently selected as the world's greatest market research company, BCC Research is a unit of Eli Global, LLC. Visit our website at www.bccresearch.com. Contact us: (+1) 781-489-7301 (U.S. Eastern Time), or email firstname.lastname@example.org.
Editors and reporters who wish to speak with the analyst should contact: